Transaction in Own Shares

PureTech Health PLC
16 January 2024
 

16 January 2024

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:             

15 January 2024



Number of ordinary shares purchased:

69,294



Highest price paid per share:

190.40p



Lowest price paid per share:

187.00p



Volume weighted average price paid per share:

188.90p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 18,386,481 ordinary shares in treasury and has 271,081,678 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 271,081,678 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

15/01/2024

08:28:31

346

190.2

BATE

00385328347TRLO0.1.1

15/01/2024

08:28:31

595

190.2

CHIX

00385328348TRLO0.1.1

15/01/2024

08:28:31

348

190.2

AQXE

00385328349TRLO0.1.1

15/01/2024

08:28:31

249

190.2

BATE

00385328350TRLO0.1.1

15/01/2024

08:28:31

595

190.2

BATE

00385328351TRLO0.1.1

15/01/2024

08:28:31

691

190.2

XLON

00385328352TRLO0.1.1

15/01/2024

08:28:31

339

190.2

XLON

00385328353TRLO0.1.1

15/01/2024

08:28:31

1350

190.2

XLON

00385328354TRLO0.1.1

15/01/2024

08:47:31

595

189.6

CHIX

00385330602TRLO0.1.1

15/01/2024

09:00:11

2217

189

XLON

00385332180TRLO0.1.1

15/01/2024

09:00:11

348

189

AQXE

00385332181TRLO0.1.1

15/01/2024

09:00:11

595

189

CHIX

00385332182TRLO0.1.1

15/01/2024

09:00:11

405

189

CHIX

00385332183TRLO0.1.1

15/01/2024

09:00:37

980

189

XLON

00385332247TRLO0.1.1

15/01/2024

09:00:37

903

189

XLON

00385332248TRLO0.1.1

15/01/2024

09:42:54

150

190.4

XLON

00385337161TRLO0.1.1

15/01/2024

09:42:54

1293

190.4

XLON

00385337162TRLO0.1.1

15/01/2024

09:42:54

595

190.4

BATE

00385337163TRLO0.1.1

15/01/2024

09:42:54

105

190.4

BATE

00385337164TRLO0.1.1

15/01/2024

09:42:54

490

190.4

BATE

00385337165TRLO0.1.1

15/01/2024

09:42:54

638

190.4

CHIX

00385337166TRLO0.1.1

15/01/2024

09:42:54

937

190.4

XLON

00385337167TRLO0.1.1

15/01/2024

09:42:54

348

190.4

AQXE

00385337168TRLO0.1.1

15/01/2024

09:42:55

210

189.8

TRQX

00385337172TRLO0.1.1

15/01/2024

09:42:55

90

189.8

TRQX

00385337173TRLO0.1.1

15/01/2024

09:42:59

903

190.4

XLON

00385337182TRLO0.1.1

15/01/2024

10:14:17

41

189.8

TRQX

00385340705TRLO0.1.1

15/01/2024

10:28:59

79

189.8

TRQX

00385342178TRLO0.1.1

15/01/2024

10:28:59

114

189.6

XLON

00385342180TRLO0.1.1

15/01/2024

10:28:59

119

189.8

TRQX

00385342179TRLO0.1.1

15/01/2024

10:28:59

141

189.6

XLON

00385342181TRLO0.1.1

15/01/2024

10:28:59

66

189.6

XLON

00385342182TRLO0.1.1

15/01/2024

10:28:59

162

189.6

XLON

00385342183TRLO0.1.1

15/01/2024

10:28:59

2795

189.6

XLON

00385342184TRLO0.1.1

15/01/2024

10:28:59

483

189.6

XLON

00385342185TRLO0.1.1

15/01/2024

10:28:59

355

189.6

XLON

00385342186TRLO0.1.1

15/01/2024

10:28:59

61

189.6

XLON

00385342187TRLO0.1.1

15/01/2024

10:28:59

61

189.6

XLON

00385342189TRLO0.1.1

15/01/2024

10:28:59

260

189.6

XLON

00385342188TRLO0.1.1

15/01/2024

10:28:59

2541

189.6

XLON

00385342190TRLO0.1.1

15/01/2024

10:28:59

61

189.6

XLON

00385342191TRLO0.1.1

15/01/2024

10:50:32

226

189.6

BATE

00385345472TRLO0.1.1

15/01/2024

10:50:32

41

189.6

XLON

00385345473TRLO0.1.1

15/01/2024

10:50:33

43

189.6

CHIX

00385345474TRLO0.1.1

15/01/2024

10:55:45

679

189.6

CHIX

00385345987TRLO0.1.1

15/01/2024

10:55:45

41

189.6

XLON

00385345988TRLO0.1.1

15/01/2024

11:36:12

132

189.6

AQXE

00385349925TRLO0.1.1

15/01/2024

11:36:12

348

189.6

AQXE

00385349926TRLO0.1.1

15/01/2024

11:36:12

41

189.6

XLON

00385349927TRLO0.1.1

15/01/2024

11:45:27

20

189.6

AQXE

00385350730TRLO0.1.1

15/01/2024

11:56:00

864

189.6

XLON

00385351572TRLO0.1.1

15/01/2024

11:56:00

475

189.6

XLON

00385351573TRLO0.1.1

15/01/2024

11:56:00

60

189.6

XLON

00385351574TRLO0.1.1

15/01/2024

12:08:53

422

189.6

BATE

00385352602TRLO0.1.1

15/01/2024

12:08:53

147

189.6

BATE

00385352603TRLO0.1.1

15/01/2024

12:08:53

110

189.6

BATE

00385352604TRLO0.1.1

15/01/2024

12:08:53

23

189.6

BATE

00385352605TRLO0.1.1

15/01/2024

12:08:53

41

189.6

XLON

00385352606TRLO0.1.1

15/01/2024

12:17:20

817

189.6

XLON

00385353539TRLO0.1.1

15/01/2024

12:17:20

383

189.6

XLON

00385353540TRLO0.1.1

15/01/2024

12:17:21

45

189.6

XLON

00385353542TRLO0.1.1

15/01/2024

12:17:22

176

189.6

BATE

00385353546TRLO0.1.1

15/01/2024

12:17:22

20

189.6

CHIX

00385353547TRLO0.1.1

15/01/2024

12:17:22

161

189.6

CHIX

00385353548TRLO0.1.1

15/01/2024

12:17:22

181

189.6

BATE

00385353549TRLO0.1.1

15/01/2024

12:17:22

433

189.6

CHIX

00385353551TRLO0.1.1

15/01/2024

12:17:22

40

189.6

BATE

00385353550TRLO0.1.1

15/01/2024

12:17:22

14

189.6

BATE

00385353552TRLO0.1.1

15/01/2024

12:17:22

100

189.6

BATE

00385353553TRLO0.1.1

15/01/2024

12:17:22

605

189.6

XLON

00385353554TRLO0.1.1

15/01/2024

12:17:22

124

189.6

TRQX

00385353555TRLO0.1.1

15/01/2024

12:17:22

21

189.6

BATE

00385353556TRLO0.1.1

15/01/2024

12:17:22

1

189.6

CHIX

00385353557TRLO0.1.1

15/01/2024

12:17:22

288

189.6

CHIX

00385353559TRLO0.1.1

15/01/2024

12:17:22

119

189.6

CHIX

00385353558TRLO0.1.1

15/01/2024

12:17:22

108

189.6

TRQX

00385353560TRLO0.1.1

15/01/2024

12:17:22

489

189.6

XLON

00385353561TRLO0.1.1

15/01/2024

12:17:24

509

189.4

XLON

00385353565TRLO0.1.1

15/01/2024

12:17:24

958

189.4

XLON

00385353564TRLO0.1.1

15/01/2024

12:17:24

903

189.4

XLON

00385353566TRLO0.1.1

15/01/2024

12:17:24

1123

189.6

XLON

00385353567TRLO0.1.1

15/01/2024

12:17:24

447

189.6

XLON

00385353568TRLO0.1.1

15/01/2024

12:17:24

903

189.6

XLON

00385353569TRLO0.1.1

15/01/2024

12:34:11

940

189.6

XLON

00385354835TRLO0.1.1

15/01/2024

12:34:11

903

189.6

XLON

00385354836TRLO0.1.1

15/01/2024

12:34:40

903

189.6

XLON

00385354863TRLO0.1.1

15/01/2024

12:34:40

353

189.6

XLON

00385354864TRLO0.1.1

15/01/2024

12:34:40

128

189.6

XLON

00385354865TRLO0.1.1

15/01/2024

12:34:42

100

188.8

XLON

00385354875TRLO0.1.1

15/01/2024

12:34:42

100

188.8

XLON

00385354877TRLO0.1.1

15/01/2024

12:34:42

2937

188.8

XLON

00385354876TRLO0.1.1

15/01/2024

12:34:42

217

188.8

TRQX

00385354878TRLO0.1.1

15/01/2024

12:35:36

1200

188.8

XLON

00385354951TRLO0.1.1

15/01/2024

12:35:36

555

188.8

XLON

00385354952TRLO0.1.1

15/01/2024

12:35:36

229

188.8

XLON

00385354953TRLO0.1.1

15/01/2024

12:35:36

6

188.8

XLON

00385354954TRLO0.1.1

15/01/2024

12:35:36

787

188.8

XLON

00385354955TRLO0.1.1

15/01/2024

12:35:37

260

188.8

XLON

00385354956TRLO0.1.1

15/01/2024

12:35:37

348

188.8

XLON

00385354957TRLO0.1.1

15/01/2024

12:35:39

11

188.8

TRQX

00385354964TRLO0.1.1

15/01/2024

12:36:04

5

188.8

TRQX

00385354989TRLO0.1.1

15/01/2024

12:41:14

18

188.8

TRQX

00385355513TRLO0.1.1

15/01/2024

12:41:14

28

188.8

TRQX

00385355512TRLO0.1.1

15/01/2024

13:08:46

601

187.8

CHIX

00385358295TRLO0.1.1

15/01/2024

13:08:46

291

187.8

AQXE

00385358297TRLO0.1.1

15/01/2024

13:08:46

182

187.8

CHIX

00385358296TRLO0.1.1

15/01/2024

13:08:47

651

187.8

XLON

00385358298TRLO0.1.1

15/01/2024

13:08:47

192

187.8

XLON

00385358299TRLO0.1.1

15/01/2024

13:08:47

95

187.8

XLON

00385358300TRLO0.1.1

15/01/2024

13:08:47

482

187.8

XLON

00385358301TRLO0.1.1

15/01/2024

13:08:47

130

187.8

XLON

00385358303TRLO0.1.1

15/01/2024

13:08:47

113

187.8

XLON

00385358302TRLO0.1.1

15/01/2024

13:08:47

472

187.8

XLON

00385358304TRLO0.1.1

15/01/2024

13:29:01

356

187

XLON

00385360215TRLO0.1.1

15/01/2024

13:56:50

2380

187.2

XLON

00385363110TRLO0.1.1

15/01/2024

13:56:50

200

187

TRQX

00385363111TRLO0.1.1

15/01/2024

13:56:50

15

187

TRQX

00385363112TRLO0.1.1

15/01/2024

13:56:51

903

187.2

XLON

00385363115TRLO0.1.1

15/01/2024

13:56:51

519

187.2

XLON

00385363116TRLO0.1.1

15/01/2024

14:15:42

126

187.2

CHIX

00385365337TRLO0.1.1

15/01/2024

14:15:42

225

187.2

CHIX

00385365338TRLO0.1.1

15/01/2024

14:15:42

40

187.2

CHIX

00385365339TRLO0.1.1

15/01/2024

14:15:42

4

187.2

CHIX

00385365340TRLO0.1.1

15/01/2024

14:15:42

200

187.4

CHIX

00385365341TRLO0.1.1

15/01/2024

14:46:54

20

187.6

AQXE

00385369749TRLO0.1.1

15/01/2024

14:46:58

2

187.6

AQXE

00385369765TRLO0.1.1

15/01/2024

14:53:38

286

187.8

CHIX

00385370862TRLO0.1.1

15/01/2024

14:53:40

48

187.6

AQXE

00385370872TRLO0.1.1

15/01/2024

14:54:35

770

187.8

CHIX

00385371004TRLO0.1.1

15/01/2024

14:54:37

58

187.6

AQXE

00385371006TRLO0.1.1

15/01/2024

14:54:57

35

187.6

AQXE

00385371071TRLO0.1.1

15/01/2024

14:55:01

4

187.6

AQXE

00385371075TRLO0.1.1

15/01/2024

15:01:59

205

187.6

TRQX

00385372315TRLO0.1.1

15/01/2024

15:01:59

2

187.6

TRQX

00385372316TRLO0.1.1

15/01/2024

15:02:36

216

187.6

AQXE

00385372390TRLO0.1.1

15/01/2024

15:02:40

19

187.6

AQXE

00385372395TRLO0.1.1

15/01/2024

15:03:23

25

187.6

AQXE

00385372523TRLO0.1.1

15/01/2024

15:18:29

206

187.6

TRQX

00385374476TRLO0.1.1

15/01/2024

15:20:47

31

187.6

AQXE

00385374682TRLO0.1.1

15/01/2024

15:20:47

25

187.6

AQXE

00385374683TRLO0.1.1

15/01/2024

15:20:47

26

187.6

AQXE

00385374684TRLO0.1.1

15/01/2024

15:51:52

43

188

CHIX

00385378549TRLO0.1.1

15/01/2024

15:51:52

338

188

CHIX

00385378550TRLO0.1.1

15/01/2024

15:51:52

206

188

CHIX

00385378551TRLO0.1.1

15/01/2024

15:51:52

100

187.6

BATE

00385378552TRLO0.1.1

15/01/2024

15:51:54

213

187.6

CHIX

00385378553TRLO0.1.1

15/01/2024

15:51:54

212

187.6

XLON

00385378554TRLO0.1.1

15/01/2024

15:51:54

300

187.6

BATE

00385378555TRLO0.1.1

15/01/2024

15:51:54

6

187.6

AQXE

00385378556TRLO0.1.1

15/01/2024

15:51:54

216

187.6

AQXE

00385378557TRLO0.1.1

15/01/2024

15:51:54

382

187.6

CHIX

00385378558TRLO0.1.1

15/01/2024

15:51:54

45

187.6

CHIX

00385378559TRLO0.1.1

15/01/2024

15:51:54

192

187.6

AQXE

00385378560TRLO0.1.1

15/01/2024

15:51:54

58

187.6

AQXE

00385378561TRLO0.1.1

15/01/2024

15:51:54

195

187.6

BATE

00385378562TRLO0.1.1

15/01/2024

15:51:54

594

187.6

BATE

00385378563TRLO0.1.1

15/01/2024

15:51:54

550

187.6

CHIX

00385378565TRLO0.1.1

15/01/2024

15:51:54

2763

187.6

XLON

00385378564TRLO0.1.1

15/01/2024

15:51:54

1

187.6

BATE

00385378566TRLO0.1.1

15/01/2024

15:51:54

224

187.6

AQXE

00385378567TRLO0.1.1

15/01/2024

15:51:54

69

187.2

TRQX

00385378568TRLO0.1.1

15/01/2024

15:51:54

62

187.2

TRQX

00385378569TRLO0.1.1

15/01/2024

15:51:55

727

187.6

BATE

00385378571TRLO0.1.1

15/01/2024

15:51:56

54

187.2

TRQX

00385378573TRLO0.1.1

15/01/2024

15:51:56

81

187.2

TRQX

00385378574TRLO0.1.1

15/01/2024

15:52:22

411

187.4

BATE

00385378635TRLO0.1.1

15/01/2024

15:57:07

2063

187

XLON

00385379641TRLO0.1.1

15/01/2024

15:57:07

203

187

XLON

00385379642TRLO0.1.1

15/01/2024

15:57:07

45

187

XLON

00385379643TRLO0.1.1

15/01/2024

15:57:07

61

187

XLON

00385379644TRLO0.1.1

15/01/2024

16:14:40

178

188.6

CHIX

00385383801TRLO0.1.1

15/01/2024

16:16:36

329

188.8

XLON

00385384383TRLO0.1.1

15/01/2024

16:16:36

117

188.8

XLON

00385384385TRLO0.1.1

15/01/2024

16:16:36

141

188.8

XLON

00385384384TRLO0.1.1

15/01/2024

16:18:51

9

188.4

AQXE

00385384959TRLO0.1.1

15/01/2024

16:26:53

1018

188.4

CHIX

00385386953TRLO0.1.1

15/01/2024

16:29:18

337

188.6

XLON

00385387441TRLO0.1.1

15/01/2024

16:29:32

233

188.6

XLON

00385387585TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings